Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients (iPACKHD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Clinical Evaluation Research Unit at Kingston General Hospital
Sponsor:
Collaborator:
Kingston General Hospital
Information provided by (Responsible Party):
Dr. Rachel Holden, Clinical Evaluation Research Unit at Kingston General Hospital
ClinicalTrials.gov Identifier:
NCT01528800
First received: February 6, 2012
Last updated: October 20, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)